Market Research Reports

Drugs of Abuse Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018

77pages
Published Date: 2014-01-28
 

Description



According to a 2013 report issued by the United Nations Office on Drugs and Crime (UNODC), there were approximately 167million users of illicit drugs such as cannabis, opioids, and opiates in 2009, which grew to 315 million users in 2011. This means that in 2009, 3.6% of the global adult population was consuming one or more illicit drug, which rose to 6.9% in 2011. This rise in the consumption of illicit drugs has led to the demand for drugs of abuse testing. Testing of drugs of abuse can be done at home, educational institutions, or workplace, or at the laboratory using many superior techniques to achieve accurate results. 

The market for drugs of abuse testing has grown in recent times owing to mounting concerns over the use of harmful drugs. The research report explains the various factors that drive and restrain the growth of the global market, players operating at various levels, and recommendations by market experts to improve the overall performance of the drugs of abuses testing market.

Overview of the global drugs of abuse testing market

The report indicates that the global market for drugs of abuse testing is forecast to grow at a 4.8% CAGR between 2013 and 2018. The market was worth US$2.6 billion in 2012, and assuming the CAGR holds true, the drugs of abuse testing market will be worth US$3.4 billion by 2018.

The rising production, trade, and consumption of illicit drugs around the world is the primary growth factor that stimulates the drugs of abuse testing market. With an increase in death rate and number of road accidents caused by drug abuse and overdose, there has arisen an urgent need for drugs of abuse testing at various organizational levels. This has boosted the drugs of abuse testing market. In regions such as Europe and North America, companies have begun conducting drug screening tests such as abstinence monitoring, pre-employment screening, post-incident drug/alcohol screening, and random drug/alcohol screening. Government regulations that support the testing of drugs of abuse at workplace have greatly fueled the global market. However, legalization of certain drugs, social inhibitions associated with the testing of illicit drugs, economic upheaval, and cost of testing threaten to hamper the growth of the drugs of abuse testing market over the forecast period. 

North America is the largest and fastest growing regional market for drugs of abuse testing and is estimated to retain its lead over the coming years. Even though on-site drug testing provides immediate results, laboratory drug screening and testing is most often preferred, since it provides accurate results and an in-depth and analytical perspective. Of the most common specimens used for testing, urine is the largest sample segment and is projected to register a 5.0% CAGR from 2013 to 2018.

Companies mentioned in the research report

The prominent players operating in the drugs of abuse testing market are Thermo Fisher Scientific, LabCorp (Laboratory Corporation of America), Psychemedics Corporation, Abbott Laboratories, Bio-Rad Laboratories, Alere, Roche Diagnostics, Sonic Healthcare, Randox Laboratories, and Quest Diagnostic. Among these, Roche Diagnostics dominates the global drugs of abuse testing market. 

Segmentation based on technology
  • Immunoassay
  • Chromatography 
Segmentation based on location
  • On-site screening test
  • Laboratory drug test
Segmentation based on sample
  • Urine
  • Hair
  • Saliva
  • Others 
Major geographies analyzed under this research report are: 
  • Europe
  • North America 
  • Asia-Pacific 
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

Table of Contents


Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Markets covered
1.3 Research methodology

Chapter 2 Executive Summary

Chapter 3 Drugs of Abuse Testing Market – Industry Analysis
3.1 Introduction
      3.1.1 International drug trafficking
      3.1.2 Drug trafficking and illicit drug use in North America
      3.1.3 Drug trafficking and illicit drug use in Europe
      3.1.4 Drug trafficking and illicit drug use in Asia-Pacific
3.2 Market Drivers
      3.2.1 Globally rising consumption of illicit drugs
      3.2.2 Adoption of drugs of abuse (DOA) testing at organizational level
      3.2.3 Increased production of illicit drugs and their trade
      3.2.4 Increasing death rates/road accidents due to drug abuse
3.3 Restraints
      3.3.1 Social concerns associated with illicit drugs testing
      3.3.2 Legalization of various drugs
      3.3.3 Economic volatility and cost concerns

Chapter 4 Porter’s five force analysis
4.1 Bargaining power of buyers
4.2 Bargaining power of suppliers
4.3 Threat from new entrants
4.4 Intensity of rivalry
4.5 Threat from substitutes

Chapter 5 Global Drugs of Abuse Testing Market

Chapter 6 Drugs of Abuse Testing Market – Testing Technology Analysis
6.1 Immunoassay Technology
6.2 Chromatography Technology

Chapter 7 Drugs of Abuse Testing Market – Sample Analysis
7.1 Laboratory drug test
7.2 On-site screening test 

Chapter 8 Single vs. Multiple Parameter Test 

Chapter 9 Drugs of Abuse Market – Regional Segment Analysis 
9.1 Scenario of drug testing in North America 
      9.1.1 Scenario of drug testing in the US 
9.2 Scenario of drug testing in Europe
      9.2.1 Scenario of drug testing in the UK
      9.2.2 Scenario of drug testing in France
      9.2.3 Scenario of drug testing in Germany
9.3 Scenario of drug testing in Asia-Pacific 
      9.3.1 Scenario of drug testing in India
      9.3.2 Scenario of drug testing in China
      9.3.3 Scenario of drug testing in Japan

Chapter 10 Recent Developments

Chapter 11 Company profiles 
11.1 Roche Diagnostics
      11.1.1 Overview 
      11.1.2 Products & Segments
      11.1.3 Financial Performance
11.2 Quest Diagnostic 
      11.2.1 Overview 
      11.2.2 Products & Segments 
      11.2.3 Financial Performance
11.3 LabCorp (Laboratory Corporation of America)
      11.3.1 Overview
      11.3.2 Products & Segments 
      11.3.3 Financial Performance 
11.4 Alere 
      11.4.1 Overview 
      11.4.2 Products and Segments
      11.4.3 Financial Performance
11.5 Abbott Laboratories
      11.5.1 Overview
      11.5.2 Products & Segments
      11.5.3 Financial Performance 
11.6 Randox Laboratories
      11.6.1 Overview
      11.6.2 Products & Segments
      11.6.3 Financial Performance
11.7 Psychemedics Corporation
      11.7.1 Overview
      11.7.2 Products & Services
      11.7.3 Financial Performance
11.8 Bio-Rad Laboratories
      11.8.1 Overview
      11.8.2 Products & Segmentation
      11.8.3 Financial Performance
11.9 Sonic Healthcare
      11.9.1 Overview
      11.9.2 Products & Services
      11.9.3 Financial Performance
11.10 Thermo Fisher Scientific
      11.10.1 Overview
      11.10.2 Products & Segments
      11.10.3 Financial performance

List of Figures 

FIG. 1 Global illicit drug users (in millions) 2009-2011
FIG. 2 Porter’s five forces analysis for drugs of abuse testing market
FIG. 3 Drug abuse testing market strategic developments (2011-2013)
FIG. 4 Company revenues (USD million, 2011-2012)
FIG. 5 Company revenues (USD million, 2011 – 2012)
FIG. 6 Company revenues (USD million, 2011 – 2012) 
FIG. 7 Company revenues (USD million, 2011 – 2012) 
FIG. 8 Company revenues (USD million, 2011 – 2012) 
FIG. 9 Company revenues (USD million, 2011 – 2012) 
FIG. 10 Company revenues (USD million, 2011-2012) 
FIG. 11 Company revenues (USD million, 2011-2012) 
FIG. 12 Company revenues (USD million, 2011-2012)

List of Tables

TABLE 1 Illicit drug users in various parts of the world, by major drugs (% share, 2011)
TABLE 2 Drivers for drugs of abuse testing market: Impact analysis
TABLE 3 Restraints for drugs of abuse testing market: Impact analysis 
TABLE 4 Global drugs of abuse testing market size, by geography 2008-2012 (USD million)
TABLE 5 Global drugs of abuse testing market size, by geography 2013-2018 (USD million)
TABLE 6 Some of the key market players offering drugs testing equipment and products
TABLE 7 Characteristics of different specimens for drug testing
TABLE 8 Global drugs of abuse testing market, by sample 2008-2012 (USD million)
TABLE 9 Global drugs of abuse testing market, by sample 2013-2018 (USD million)
TABLE 10 Advantage and disadvantage of laboratory drug screening test
TABLE 11 Advantage and disadvantage of on-site drug screening test
TABLE 12 Global drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 13 Global drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 14 Advantages of multi panel drug test over single paned drug test
TABLE 15 North American drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 16 North American drugs of abuse testing market, by geography 2013-2018 (USD million)
TABLE 17 North American drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 18 North American drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 19 US drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 20 US drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 21 European drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 22 European drugs of abuse testing market, by geography 2013-2018 (USD million)
TABLE 23 European drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 24 European drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 25 UK drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 26 UK drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 27 France drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 28 France drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 29 Germany drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 30 Germany drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 31 Asian drugs of abuse testing market, by geography 2008-2012 (USD million)
TABLE 32 Asian drugs of abuse testing market, by geography 2013-2018 (USD million) 
TABLE 33 Asian drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 34 Asian drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 35 Indian drugs of abuse testing market, by test location 2008-2012 (USD thousand)
TABLE 36 Indian drugs of abuse testing market, by test location 2013-2018 (USD thousand)
TABLE 37 China drugs of abuse testing market, by test location 2008-2012 (USD thousand)
TABLE 38 China drugs of abuse testing market, by test location 2013-2018 (USD thousand)
TABLE 39 Japan drugs of abuse testing market, by test location 2008-2012 (USD million)
TABLE 40 Japan drugs of abuse testing market, by test location 2013-2018 (USD million)
TABLE 41 Major product launches in drugs of abuse testing market (2011-2013)
TABLE 42 Mergers and acquisitions in drugs of abuse testing market (2011-2013)
TABLE 43 Partnerships in drugs of abuse testing market (2011-2013)

Enquiry Before Buying


Free Market Analysis


Globally, the drugs of abuse testing market is witnessing significant growth due to rising awareness of government and non-government organizations towards ill effects of illicit drugs and to control socio-economical losses associated with drug abuse. As a result, this market is expected to grow at a CAGR of about 4.8% during 2013 – 2018.

Some of the key driving factors for the drugs of abuse testing market are globally rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns. 

North America, including the US has the largest drugs of abuse testing market and also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population; cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, such as in America and Europe, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. 

In many countries, government rules & regulations are also supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market
Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about 5.0% during 2013 – 2018. Some of the other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives immediate results on the spot. It is generally preferred by those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only. 

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research